The Influence of Hydro-Alcoholic Media on Drug Release - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Influence of Hydro-Alcoholic Media on Drug Release
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.


Pharmaceutical Technology
Volume 35, Issue 7, pp. 50-58

26. H.M. Fadda, M.A.M Mohamed, and A.W. Basit, Int. J. Pharm. 360 (1-2) 171–176 (2008).

27. M. Walden et al., Drug. Dev. Ind. Pharm. 33 (10) 1101–1111 (2007).

28. J. Koziara, J. So, and N. Agarwal, presentation at the AAPS Annual Meeting and Exposition (San Antonio, TX, 2006).

29. M. Roberts et al., Int. J. Pharm. 332 (1-2) 31–37 (2007).

30. M.J. Traynor et al., Drug. Dev. Ind. Pharm. 34 (8) 885–889 (2008).

31. S. Missaghi, K.A. Fegely, and A.R. Rajabi-Siahboomi, AAPS. PharmSci. 10 (1) 77–80 (2009).

32. B. Ager et al., presentation at the 36th Annual Meeting & Exposition of the Controlled Release Society (Copenhagen, Denmark, 2009).

33. J.E.F. Reynolds, K. Parfitt, A.V. Parsons, S.C. Sweetman, Eds., Martindale, The Extra Pharmacopoeia, 29th ed. (Pharmaceutical Press, London, UK, 1989).

34. A.C. Moffat, M.D. Osselton, and B. Widdop, Eds., Clarke's Analysis of Drugs and Poisons, Vol. 2 (Pharmaceutical Press, London, 2004).

35. N. Seedher, and M. Kanojia, Pharm. Dev. Technol. 14 (2) 185–192 (2009).

36. F.E. Bailey Jr. and J.V. Koleski, Poly(ethy1ene oxide), Chapter 5 (Academic Press, New York, 1976) p. 87.

37. Colorcon "HyperStart services," http://www.colorcon.com/ (2010).

38. FDA, "The Influence of Hydrophilic Pore Formers on Dipyridamole Release from Aqueous Ethylcellulose Film-Coated Pellets," Fed. Regist., 60 (230) p.61642 (1995).

39. P.L. Ritger, and N.A. Peppas, J. Control. Release. 5 (1) 23–36 (1987).

40. P.L. Ritger and N.A. Peppas, J. Control. Release. 5 (1) 37–42 (1987).

41. R. Espinoza, E. Hong, and L. Villafuerte, Int. J. Pharm. 201 (2) 165–173 (2000).

42. J.L. Ford et al., Int. J. Pharm. 71 (1-2) 95–104 (1991).

43. N.K. Ebube et al., Int. J. Pharm. 156 (1) 49–57 (1997).

44. N.K. Ebube et al., Pharm. Dev. Technol. 2 (2) 161–170 (1997).

45. K. Tahara, K. Yamamoto, and T. Nishihata, J. Control. Release. 35 (1) 59–66 (1995).

46. N. Kavanagh and O.I. Corrigan, Int. J. Pharm. 279 (1-2) 141–152 (2004).

47. S.P. Panomsuk et al., Chem. Pharm. Bull. 44 (5) 1039–1042 (1996).

48. J.C. Bode and C. Bode, Alcohol Malnutrition and the Gastrointestinal Tract, in: Nutrition and Alcohol, R.R. Watson, B. Watzl, Eds. (CRC Press, Boca Raton, FL, 1992) pp. 403–428.

49. C. Bode, J.C. Bode, Alcohol. Health. Res. W. 21 (1) 76–83 (1997).

50. A.F. Brown, D.S. Jones, and A.D. Woolfson, supplement to J. Pharm. Pharmacol. 50 157 (1998).

51. D.S. Jones et al., presentation at the AAPS Annual Meeting and Exposition (Toronto, ON, Canada, 2002).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here